Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-056301
Filing Date
2011-03-04
Accepted
2011-03-04 16:31:10
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1294017
2 OFFER LETTER - DONALD KELLERMAN dex1029.htm EX-10.29 18963
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1548
4 CERTIFICATION OF PEO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 9820
5 CERTIFICATION OF PFO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 9844
6 CERTIFICATION OF PEO AND PFO REQUIRED UNDER RULE 13A-14(B) dex321.htm EX-32.1 5981
7 GRAPHIC g146975g53c64.jpg GRAPHIC 27199
8 GRAPHIC g146975g65c43.jpg GRAPHIC 53762
  Complete submission text file 0001193125-11-056301.txt   1453003
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-33719 | Film No.: 11665047
SIC: 2834 Pharmaceutical Preparations